Sage Journals: Discover world-class research

Open access

Research article

First published 2018-7

High prevalence and indexes of anti-John Cunningham virus antibodies in a cohort of Chinese patients with multiple sclerosis

Alexander Lau, Wei Qiu, Allan Kermode [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Letter

First published 2020-1

Serum anti-John Cunningham virus antibody seroprevalence and index among Japanese patients with neuromyelitis optica spectrum disorders

Shinji Aoyama, Masahiro Mori, Akiyuki Uzawa [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2021-7

The effect of tonsillectomy on John Cunningham virus serological status in multiple sclerosis patients: A retrospective case–control study

Mirla Avila, Annette Okai, Smathorn Thakolwiboon [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2015-10

Longitudinal JCV serology in multiple sclerosis patients preceding natalizumab-associated progressive multifocal leukoencephalopathy

Anke Vennegoor, Johannis A van Rossum, Chris H Polman [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2022-7

Immune cell subset profiling in multiple sclerosis after fingolimod initiation and continued treatment: The FLUENT study

Yang Mao-Draayer, Jeffrey A Cohen, Amit Bar-Or [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Review article

First published 2018-4

Anti-JCV serology during natalizumab treatment: Review and meta-analysis of 17 independent patient cohorts analyzing anti-John Cunningham polyoma virus sero-conversion rates under natalizumab treatment and differences between technical and biological sero-converters

Nicholas Schwab, Tilman Schneider-Hohendorf, Tammy Hoyt [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2019-1

The FLUENT study design: investigating immune cell subset and neurofilament changes in patients with relapsing multiple sclerosis treated with fingolimod

Jeffrey A Cohen, Amit Bar-Or, Bruce A C Cree [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Open access

Research article

First published 2023

Alemtuzumab following natalizumab is more effective in adult-onset than paediatric-onset multiple sclerosis

Marco Puthenparampil, Marta Gaggiola, Alessandro Miscioscia [...]

Therapeutic Advances in Neurological Disorders

Open access

Review article

First published 2017-9

The role of natalizumab in the treatment of multiple sclerosis: benefits and risks

Barry A. Singer

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 2025-6

Beyond the switch to the biosimilar of natalizumab: What is the impact of changing the JCV test?

Sandra Vukusic, Florian Hubben, Antoine Gavoille [...]

Multiple Sclerosis Journal

Search results